Shannon Campbell

Executive Vice President and Chief Commercial Officer, Merus

Shannon Campbell serves as the Executive Vice President and Chief Commercial Officer at Merus, a clinical-stage oncology company engaged in developing multispecific antibody therapeutics. With over thirty years of biopharmaceutical experience, Shannon possesses deep expertise in commercializing transformative medicines globally. She has a proven track record of success in strategy development, team building, and driving results across diverse markets, geographies, and product lifecycles. Shannon has served as Merus’s Chief Commercial Officer since February 2022 where she is responsible for Merus’s global commercialization strategy and activity. Before joining Merus, Shannon led the U.S. Solid Tumor Franchise at Novartis from 2017 until 2022, overseeing a broad portfolio of oncology and rare disease products. Prior to Novartis, from 2005 until 2017, Shannon played a key role in launching and leading the US Oncology Business Unit at Bayer HealthCare Pharmaceuticals, most recently as Vice President & General Manager, Oncology. Her earlier career includes positions of increasing responsibility at Abbott Labs and Pharmacia heritage companies.

Shannon holds a Bachelor of Science degree from Ithaca College and has completed leadership, strategy, and finance programs at the University of Michigan Ross School of Business, IMD, Harvard Business School, and The Wharton School, University of Pennsylvania.